The PI3K/AKT pathway is a well-established regulator of proliferation, survival, and metabolism, and its aberrant activation in HCC has been consistently linked to tumor progression, metastasis, and drug resistance (Li et al., 2022; Wan et al., 2024). This evidence concerns the gene AKT1 and hepatocellular carcinoma.